Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+10,055,474
Put/Call ratio
34%
SEC-reported price per share
$8.38
Number of holders
232
Value change
+$84,513,755
Number of buys
138
Open additional details 1 more signal available
Number of sells
66
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
348,532,261

Security key

03168L105

Report period

Q1 2025

Institutions

232

Top holders

10

Ownership snapshot

Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Akram Mahesh
Disclosed value leader
Akram Mahesh
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G 13F 3/4/5 Lead comparable stake: 6.6% 13D/G row: Akram Mahesh Showing 1-6 of 15 holder rows.

Quick read

Akram Mahesh leads the comparable SEC ownership view at 6.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Akram Mahesh's linked filing trail.
Comparable ownership Top 5
Akram Mahesh 6.6%
VANGUARD GROUP INC 5%
BlackRock, Inc. 3.6%
TPG GP A, LLC 3.5%
Rubric Capital Management LP 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Akram Mahesh
13D/G
6.6%
$153,779,517
20,558,759 shares
$0 31 Mar 2025
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
5%
$117,905,198
15,762,727 shares
$0 31 Mar 2025
BlackRock, Inc.
13F
Company
13F
3.6%
$99,697,040
12,588,010 shares
31 Dec 2024
TPG GP A, LLC
13F 3/4/5
Company · Former 10% Owner
3.5%
$97,643,835
12,328,767 shares
31 Dec 2024
Rubric Capital Management LP
13F
Company
13F
3.1%
$84,916,482
10,721,778 shares
31 Dec 2024
CITADEL ADVISORS LLC
13F
Company
13F
2.6%
$71,129,266
8,980,968 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
232
Shares
134,631,456
Rows available
232
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders
232
Q1 2025 holders
232
Holder diff
0
Investor Q1 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2025 value Q1 2025 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .